Understanding albumin better through R&D collaborations
In Albumedix we partner with excellence to improve therapies for people with serious diseases by continuing to explore the vast possibilities of albumin and the continued support of albumin science.
We are always seeking partners and collaborators to unlock the full potential of native and engineered albumin to create superior biotherapeutics through the understanding of albumin science and its applications.
We have already established a range of scientific collaborations with both academia and industry with whom we together share knowledge and experience within albumin science to further a shared vision of creating better therapies for patients.
Some of our collaborators include:
(click on logos to visit our collaborators)
Albumedix is interested in pioneering technologies that enhance our offering and internal R&D efforts. Consequently, we are frequently evaluating complementary technologies and have secured strong solution collaborations that are already benefitting our partners.
If you are interested in partnering opportunities with Albumedix you are always welcome to contact us to discuss further. CONTACT ALBUMEDIX NOW
Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with more than 80 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.